107,904views
00:00 / 00:00
test 4
Diabetes insipidus
Diabetes mellitus: Clinical (To be retired)
Diabetes mellitus
Diabetes mellitus: Pathology review
Graves disease
Hyperthyroidism: Nursing Process (ADPIE)
Hyperthyroidism
Hyperthyroidism: Pathology review
Hyperparathyroidism
Hyperparathyroidism: Nursing
Hypopituitarism
Hypopituitarism: Clinical (To be retired)
Hypopituitarism: Pathology review
Hypothyroidism
Hypothyroidism: Nursing Process (ADPIE)
Hypothyroidism: Pathology review
Metabolic acidosis
Metabolic alkalosis
Prolactinoma
Thyroid cancer
Thyroid nodules and thyroid cancer: Clinical (To be retired)
Thyroid nodules and thyroid cancer: Pathology review
Anemia: Clinical (To be retired)
Macrocytic anemia: Pathology review
Aplastic anemia
Warm autoimmune hemolytic anemia and cold agglutinin (NORD)
Disseminated intravascular coagulation
Acute disseminated encephalomyelitis
Hemophilia
Hemophilia: Nursing Process (ADPIE)
Thrombocytopenia: Clinical (To be retired)
Heparin-induced thrombocytopenia
Immune thrombocytopenic purpura
Thrombotic thrombocytopenic purpura
Leukemia: Nursing Process (ADPIE)
Chronic leukemia
Leukemias: Pathology review
Acute leukemia
Leukemia: Clinical (To be retired)
Lymphomas: Pathology review
Lymphoma: Clinical (To be retired)
Hodgkin lymphoma
Non-Hodgkin lymphoma
Lymphatic system anatomy and physiology
Multiple endocrine neoplasia: Pathology review
Multiple endocrine neoplasia
Sickle cell disease (NORD)
Sickle cell disease: Clinical (To be retired)
Sickle-cell disease: Nursing Process (ADPIE)
Deep vein thrombosis
Deep vein thrombosis and pulmonary embolism: Pathology review
Von Willebrand disease
von Hippel-Lindau disease
Allergic rhinitis
Antibody classes
Pediatric allergies: Clinical (To be retired)
Food allergies and EpiPens: Information for patients and families (The Primary School)
Anaphylaxis: Nursing Process (ADPIE)
Anaphylaxis
Appendicitis: Nursing Process (ADPIE)
Appendicitis: Pathology review
Appendicitis
Appendicitis: Clinical (To be retired)
Gonorrhea & chlamydia: Nursing Process (ADPIE)
Chlamydia pneumoniae
Chlamydia trachomatis
Clostridium difficile (Pseudomembranous colitis)
Viral hepatitis: Pathology review
Viral hepatitis: Clinical (To be retired)
Hepatitis C virus
Hepatitis
Hepatitis A and Hepatitis E virus
Herpes simplex virus
Herpesvirus medications
Human parainfluenza viruses
HIV (AIDS)
Antiretrovirals for HIV/AIDS - NRTIs & NNRTIs: Nursing Pharmacology
Antiretrovirals for HIV/AIDS - Protease inhibitors: Nursing Pharmacology
Antiretrovirals for HIV/AIDS - Integrase strand transfer inhibitors: Nursing Pharmacology
Human papillomavirus
Influenza virus
The flu vaccine: Information for patients and families
Vaccinations
Legionella pneumophila (Legionnaires disease and Pontiac fever)
Borrelia burgdorferi (Lyme disease)
Lyme disease: Nursing Process (ADPIE)
Lyme Disease
Meningitis: Nursing Process (ADPIE)
Meningitis
Meningitis, encephalitis and brain abscesses: Clinical (To be retired)
Epstein-Barr virus (Infectious mononucleosis)
Pelvic inflammatory disease
Pelvic inflammatory disease (PID): Nursing Process (ADPIE)
Pneumonia: Pathology review
Pneumonia
Pneumonia: Clinical (To be retired)
Mycobacterium tuberculosis (Tuberculosis)
Tuberculosis: Pathology review
Urinary tract infections (UTI): Nursing Process (ADPIE)
Urinary tract infections: Pathology review
Lower urinary tract infection
Urinary tract infections: Clinical (To be retired)
Gardnerella vaginalis (Bacterial vaginosis)
Chickenpox (Varicella): Nursing Process (ADPIE)
Varicella zoster virus
Immune thrombocytopenic purpura
0 / 13 complete
0 / 2 complete
of complete
of complete
Laboratory value | Result |
Hematologic | |
Hemoglobin | 12 g/dL |
Hematocrit | 40% |
Platelet count | 95,000/mm3 |
Leukocyte count | 9,000/mm3 |
Coagulation studies | |
Prothrombin time (PT) | 12 seconds |
Activated partial thromboplastin time (aPTT) | 29 seconds |
Bleeding time* | 15 minutes |
Robyn Hughes, MScBMC
Evan Debevec-McKenney
Immune thrombocytopenic purpura or ITP is an autoimmune condition in which the body produces antibodies against its own thrombocytes or platelets, which are destroyed. And this result in purpura, or small bleeding spots beneath the skin.
Normally, when there’s any kind of damage to the blood vessel, hemostasis occurs, which is the process that stops the bleeding and plugs the damaged vessel to limit the blood loss.
And there are two steps: primary and secondary hemostasis. During primary hemostasis, platelets aggregate to form a plug at the site of an injured blood vessel.
Platelet aggregation is mediated by surface proteins found on platelets, called GP2B3A receptors. While these platelets are aggregating, secondary hemostasis kicks in.
Secondary hemostasis is also called coagulation, because that’s when clotting factors come into play one after another, with a view to cleaving fibrinogen into fibrin.
Then, fibrin forms a protein mesh, kinda like a giant net that covers the platelet plug and stabilizes it.
Now, in ITP, the spleen produces certain IgG autoantibodies which bind to the platelet receptor Gp2B3A, and target the platelet-antibody complexes for destruction in the spleen.
This leads to lowering of platelet counts in the blood, which makes it harder for bleeding to stop. Now, ITP can be acute or chronic.
Copyright © 2023 Elsevier, except certain content provided by third parties
Cookies are used by this site.
USMLE® is a joint program of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). COMLEX-USA® is a registered trademark of The National Board of Osteopathic Medical Examiners, Inc. NCLEX-RN® is a registered trademark of the National Council of State Boards of Nursing, Inc. Test names and other trademarks are the property of the respective trademark holders. None of the trademark holders are endorsed by nor affiliated with Osmosis or this website.